Related Experiment Video
Updated: Aug 22, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Outcomes of critically ill coronavirus disease 2019 patients requiring kidney replacement therapy: A retrospective
Josephine Braunsteiner1, Dominik Jarczak1, Christian Schmidt-Lauber2
1Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Insights
Nearly half of critically ill COVID-19 patients require kidney replacement therapy (KRT). This KRT initiation is linked to significantly higher intensive care unit (ICU) mortality rates.
Area of Science:
- Nephrology
- Critical Care Medicine
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) is a significant global health crisis with high hospitalization rates.
- Acute kidney injury (AKI) is a common complication in COVID-19 patients, correlating with disease severity and adverse outcomes.
- Understanding the need for kidney replacement therapy (KRT) and its impact on outcomes in critically ill COVID-19 patients is crucial.
Purpose of the Study:
- To determine the incidence of kidney replacement therapy (KRT) among critically ill patients with COVID-19.
- To investigate the factors associated with the initiation of KRT in this patient population.
- To evaluate the implication of KRT on mortality in critically ill COVID-19 patients.
Main Methods:
- Retrospective analysis of COVID-19 patients admitted to the Intensive Care Medicine department.
- Data collection included demographics, clinical parameters, organ support, ICU stay length, mortality, and severity scores.
- Statistical analysis, including logistic and Cox regression, was used to identify factors associated with KRT and mortality.
Main Results:
- Out of 300 critically ill COVID-19 patients, 46% required KRT.
- Factors independently associated with KRT initiation included septic shock, higher SAPS II scores, and vasopressor therapy.
- Mortality in the ICU was significantly higher for patients who received KRT (61%) compared to those who did not (18%).
Conclusions:
- Critically ill COVID-19 patients face a high risk of AKI, with approximately half requiring KRT.
- KRT initiation in this cohort is independently associated with increased ICU mortality.
- Early identification and management of AKI risk factors in COVID-19 patients are essential.
Background:
Coronavirus disease 2019 (COVID-19) has resulted in high hospitalization rates worldwide. Acute kidney injury (AKI) in patients hospitalized for COVID-19 is frequent and associated with disease severity and poor outcome. The aim of this study was to investigate the incidence of kidney replacement therapy (KRT) in critically ill patients with COVID-19 and its implication on outcome.
Methods:
We retrospectively analyzed all COVID-19 patients admitted to the Department of Intensive Care Medicine at the University Medical Center Hamburg-Eppendorf (Germany) between 1 March 2020 and 31 July 2021. Demographics, clinical parameters, type of organ support, length of intensive care unit (ICU) stay, mortality and severity scores were assessed.
Results:
Three-hundred critically ill patients with COVID-19 were included. The median age of the study population was 61 (IQR 51-71) years and 66% (n = 198) were male. 73% (n = 219) of patients required invasive mechanical ventilation. Overall, 68% (n = 204) of patients suffered from acute respiratory distress syndrome and 30% (n = 91) required extracorporeal membrane oxygenation (ECMO). We found that 46% (n = 139) of patients required KRT. Septic shock (OR 11.818, 95% CI: 5.941-23.506, p < 0.001), higher simplified acute physiology scores (SAPS II) (OR 1.048, 95% CI: 1.014-1.084, p = 0.006) and vasopressor therapy (OR 5.475, 95% CI: 1.127-26.589, p = 0.035) were independently associated with the initiation of KRT. 61% (n = 85) of patients with and 18% (n = 29) without KRT died in the ICU (p < 0.001). Cox regression found that KRT was independently associated with mortality (HR 2.075, 95% CI: 1.342-3.208, p = 0.001) after adjusting for confounders.
Conclusion:
Critically ill patients with COVID-19 are at high risk of acute kidney injury with about half of patients requiring KRT. The initiation of KRT was associated with high mortality.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Kidney Transplant I: Introduction
Continuous Renal Replacement Therapy

